Skip to main content

Table 2 Serial hematocrit measurements in rats after MI, showing that EPO-transduced cell injection does not increase systemic hematocrit levels

From: Transplantation of genetically engineered cardiac fibroblasts producing recombinant human erythropoietin to repair the infarcted myocardium

Treatment time

Saline (n = 9)

EPO-transduced cells (n = 9)

Non-transduced cells (n = 9)

Baseline (before injection; %)

47.5 ± 0.3

47.2 ± 0.2

47.2 ± 0.1

1 week post-injection (%)

47.4 ± 0.2

47.0 ± 0.1

47.39 ± 0.2

4 weeks post-injection (%)

47.4 ± 0.18

46.8 ± 0.2

47.15 ± 0.2

  1. p = 1.00.